Opinion|Videos|May 22, 2024
Overview of Clinical Trials for New Imaging Options for Kidney Cancer
Author(s)Neal Shore, MD, FACS, Brian M. Shuch, MD
Urologists review clinical trials investigating new imaging options in kidney cancer, including the ZIRCON study looking at girentuximab.
Advertisement
Episodes in this series
Advertisement
Related to this article
William Huang, MD, discusses histotripsy for renal tumors, the #HOPE4KIDNEY trial, and the technology’s potential to preserve kidney function.
The final analysis confirmed PFS and response benefits in previously treated advanced clear cell renal cell carcinoma, but the OS difference did not cross the prespecified significance boundary.
Brian I. Rini, MD, FASCO, explains why LITESPARK-012’s negative triplet results still offer lessons on drug delivery and building on first-line RCC doublets.
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants De Novo authorization to Virtuoso Robotic System for bladder tumor resection
2
Survey: Service members and veterans with NMIBC report barriers to treatment access
3
BCG-naïve NMIBC: Optimizing initial treatment selection
4
Q&A: Ronald Anglade, MD, on genetic testing in male infertility
5